Table 1.

Compare between ELMO1-AS1 expression and clinicopathological characteristics in HCC patients

	Training set				Validation set				Combined set
Clinicopathologic Parameters	Total (n=110)	Low (n=55)	High (n=55)	P-value	Total (n=112)	Low (n=56)	High (n=56)	P-value	Total (n=222)	Low (n=111)	High (n=111)	P-value
Gender				0.801				0.341				0.239
Female	19	9	10		11	4	7		30	12	18
Male	91	46	45		101	52	49		192	99	93
Age (years)				0.057				0.280				1.000
<55	88	40	48		96	50	46		184	92	92
≥55	22	15	7		16	6	10		38	19	19
Tumor number				0.606				0.645				0.304
<3	92	47	45		88	43	45		180	93	87
≥3	18	8	10		24	13	11		42	18	21
Tumor diameter				0.189				0.357				0.113
<5 cm	28	11	17		24	10	14		52	21	31
≥5 cm	82	44	38		88	46	42		170	90	80
AFP				1.000				0.057				0.178
<400 ng/ml	58	29	29		50	20	30		108	49	59
≥400 ng/ml	52	26	26		62	36	26		114	62	52
PVTT				0.039				1.000				0.178
No	97	45	52		94	47	47		191	92	99
Yes	13	10	3		18	9	9		31	19	12
Microsatellite				0.185				0.324				0.239
No	100	48	52		92	44	48		192	93	99
Yes	10	7	3		20	12	8		30	18	12
MVI				0.340				0.038				0.060
No	55	25	30		55	22	33		110	48	62
Yes	55	30	25		57	34	23		112	63	49
TNM stage				0.152				0.287				0.139
I+II	75	34	41		72	34	38		147	69	78
III+IV	35	21	14		38	22	16		73	42	31

Abbreviations: AFP, alpha-fetoprotein; PVTT, portal vein tumor thrombus; MVI, microvascular invasion.